.png)
Protein aggregation occurs in the biopharmaceutical pipeline, from development, formulation, and manufacturing to storage and point of use. Spheryx's proprietary technology, Total Holographic Characterization, detects, counts and characterizes protein aggregates in formulation and manufacturing while distinguishing them from other contaminants. Spheryx's xSight uses Total Holographic Characterization to determine the concentration of multiple different contaminants in a heterogeneous sample, simultaneously, even when they are the same size. xSight also determines the morphology of particles as well as their size and composition in the critical size range of 500 nm - 10 um. Spheryx's custom, disposable microfluidic sample chips ensure that there is no cross-contamination between samples without the need for cleaning between samples. In addition, automated sample delivery is available with xStream, xSight's custom robotic sample loader.